Home » Stocks » RNVA

Rennova Health, Inc. (RNVA)

Stock Price: $0.0300 USD -0.0075 (-20.00%)
Updated November 23, 4:00 PM EST - End of day

Stock Price Chart

Key Info

Market Cap 35,367
Revenue (ttm) 7.62M
Net Income (ttm) -138.18M
Shares Out 1.18M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $0.0300
Previous Close $0.0375
Change ($) -0.0075
Change (%) -20.00%
Day's Open 0.0337
Day's Range 0.0280 - 0.0385
Day's Volume 897,106
52-Week Range 0.0100 - 4.0000

More Stats

Market Cap 35,367
Enterprise Value 19.64M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 1.18M
Float 1.18M
EPS (basic) 65.14
EPS (diluted) -0.03
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 226
Short Ratio 0.84
Short % of Float 0.02%
Beta 53.11
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.00
PB Ratio n/a
Revenue 7.62M
Operating Income -13.65M
Net Income -138.18M
Free Cash Flow -14.46M
Net Cash -19.61M
Net Cash / Share -16.63
Gross Margin 7.14%
Operating Margin -179.24%
Profit Margin -1,814.50%
FCF Margin -189.89%
ROA -70.62%
ROE n/a
ROIC 175.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $0.0300
Target: 41,625,001,984
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth38.37%570.37%-24.32%64.5%300%525%---60.3%-
Gross Profit3.672.090.430.500.340.100.02-5.2014.01
Operating Income-16.08-22.49-5.44-3.59-4.10-2.52-1.87-2.33-7.941.60
Net Income-55.20-32.61-5.16-3.31-3.93-1.43-3.13-18.47-7.9018.10
Shares Outstanding2.310.07--------
Earnings Per Share-47.02-452.58-6,840.00-7,605.00-9,540.00-3,825.00-8,325.00-49,320.00-22,725.0055,800.00
Operating Cash Flow-17.71-19.86-3.57-2.43-3.84-3.11-0.07-4.89-5.54-5.06
Capital Expenditures-1.42-0.02-0.02-0.02-0.12--0.07-0.83-0.46-0.48
Free Cash Flow-19.14-19.88-3.58-2.45-3.96-3.11-0.14-5.72-6.00-5.54
Cash & Equivalents0.180.217.521.814.047.827.787.3012.4919.27
Total Debt15.5312.910.530.510.50----0.01
Net Cash / Debt-15.35-12.706.991.303.547.827.787.3012.4919.26
Book Value-40.61-14.897.942.935.708.089.4111.9430.0332.93
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Rennova Health, Inc.
Country United States
CEO Seamus Lagan

Stock Information

Ticker Symbol RNVA
Stock Exchange US OTC
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier OTCMKTS: RNVA


Rennova Health, together with its subsidiaries, engages in the hospital operations in the United States. It operates in two segments, Hospital Operations and Clinical Laboratory Services. The company provides a suite of healthcare related products and services for healthcare providers, patients, and individuals. It also offers diagnostic imaging, radiology, surgery, nuclear medicine, wound care and hyperbaric medicine, intensive care, emergency care, and physical therapy services; and X-ray, mammography, bone densitometry, computed tomography, ultrasound, physical therapy, and laboratory services. In addition, the company provides blood and urine, toxicology, clinical pharmacogenetics, and esoteric testing services. Further, it invests in and develops a suite of software products to its diagnostics business. Additionally, the company owns three hospitals, a physician's office in Tennessee, and a rural clinic in Kentucky. Rennova Health, Inc. was founded in 2005 and is based in West Palm Beach, Florida.